$785 Million for Tropical Diseases

A public-private partnership including 13 pharmaceutical companies pledge more than $785 million to fight neglected tropical diseases.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Bill Gates at the World Economic Forum Annual Meeting on Jan 26, 2012FLICKR, WORLD ECONOMIC FORUM

Some are calling it an unprecedented collaboration: 13 pharmaceutical companies, the Bill and Melinda Gates Foundation, the World Health Organization, The World Bank, and the US, UK, and UAE governments, and other groups have come together to fight neglected tropical diseases. Neglected tropical diseases tend to afflict the world’s poorest people, and thus companies have fewer incentives to invest in medicines and cures.

The partnership, announced yesterday (January 30) at the Royal College of Physicians in London, will focus on ten tropical diseases, including Chagas disease, guinea worm, and sleeping sickness. Drugmakers agreed to continue or expand drug donation programs through 2020 while sharing protocols and materials with one another to hasten new drug development. In total, the groups donated more than $785 million for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours